Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2023-12-22 Director's Dealing
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec SE: Dr. Werner Lanthaler, buy
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of a member of the managing body (Dr. Werner Lanthaler), the nature of the transaction ('Acquisition'), the financial instrument (Share), and the price/volume. This content directly matches the definition for Director's Dealing.
2023-12-22 English
Evotec SE: Dr. Werner Lanthaler, buy
Director's Dealing Classification · 1% confidence The document explicitly contains the header "Directors’ Dealings" and details a "Notification and public disclosure of transactions by persons discharging managerial responsibilities." Section 1 identifies the person (Dr. Werner Lanthaler, Member of the managing body), and Section 4 details the transaction (Acquisition of Shares). This content directly matches the definition for Director's Dealing.
2023-12-22 English
Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes
Regulatory Filings Classification · 1% confidence The document is a news release dated December 19, 2023, announcing that Evotec SE received a US$ 2.5 million grant from the Bill & Melinda Gates Foundation to leverage its teratogenicity platform. It details the nature of the grant, the scientific platform, and includes standard corporate boilerplate and contact information. This type of announcement, which communicates a specific, non-periodic corporate event (like a grant award or partnership), is typically classified as a general Regulatory Filing or News Release if it doesn't fit a more specific category like Earnings Release (ER) or Capital Update (CAP). Since it is not a full financial report (10-K, IR), a management discussion (MDA), or a specific shareholder action (DIV, DVA), the most appropriate general category for a significant, non-standard corporate announcement distributed via EQS News is Regulatory Filings (RNS), which serves as the miscellaneous regulatory announcement fallback.
2023-12-19 English
Evotec enters partnership with Charite to expand molecular patient database in autoimmune diseases
Environmental & Social Information Classification · 1% confidence The document is a news release dated December 14, 2023, announcing a strategic partnership between Evotec SE and Charité Universitätsmedizin Berlin regarding the expansion of a molecular patient database for autoimmune diseases. It uses the EQS-News format and contains standard corporate announcement elements like key highlights, commentary from executives, and boilerplate forward-looking statements. This type of announcement, detailing a business development or strategic agreement that is not a core financial report (like 10-K or IR) or a specific regulatory filing (like DIRS or DIV), falls best under the general 'Regulatory Filings' or 'Miscellaneous' category based on the provided definitions. Since 'Regulatory Filings (RNS)' is defined as 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories,' and this is a general corporate news announcement, RNS is the most appropriate classification.
2023-12-14 English
Evotec-partner Jingxin receives approval for EVT201 in China
Regulatory Filings Classification · 1% confidence The document is a news release dated December 6, 2023, originating from Evotec SE via EQS News. It announces that Evotec's partner, Jingxin, received approval from the Chinese NMPA for the drug EVT201. The content focuses on a specific corporate development (drug approval and partnership details) rather than a comprehensive financial report (like 10-K or IR) or a standard regulatory filing like a director's dealing or capital change. Since it is a specific corporate announcement that doesn't fit the highly specific categories like ER, DIV, or MANG, and it is not a presentation (IP) or a transcript (CT), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous corporate news releases distributed via regulatory channels, although 'RPA' (Report Publication Announcement) is sometimes used for news releases, this is a substantive news item, not just an announcement *about* a report. Given the options, RNS is the most appropriate catch-all for this type of material news release.
2023-12-06 English
Declaration of Compliance with the German Corporate Governance Code for the year 2023
Governance Information Classification · 1% confidence The document is explicitly titled 'DECLARATION OF COMPLIANCE BY THE MANAGEMENT BOARD AND SUPERVISORY BOARD WITH THE GERMAN CORPORATE GOVERNANCE CODE FOR THE YEAR 2023'. It details compliance with the German Corporate Governance Code (DCGK) as required by Section 161 of the German Stock Corporation Act (AktG). This type of declaration, focusing on internal rules, board structure, and governance practices, directly aligns with the definition of Governance Information (CGR). The document is not a general regulatory filing (RNS) because it fits a specific governance category, nor is it an announcement of a report (RPA) as it contains the actual declaration content.
2023-12-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.